MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$7.01
Change
+$0.20 (+2.94%)
Capitalization
262.64M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges... Show more

LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
Sep 26, 2025

LFCR in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 10, 2025

LFCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where LFCR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on September 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 183 cases where LFCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on September 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

LFCR moved below its 50-day moving average on September 24, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LFCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LFCR's P/B Ratio (196.078) is slightly higher than the industry average of (16.941). P/E Ratio (51.231) is within average values for comparable stocks, (73.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.959). LFCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.894) is also within normal values, averaging (45.936).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LFCR is expected to report earnings to rise 425.00% to -31 cents per share on October 02

Lifecore Biomedical LFCR Stock Earnings Reports
Q3'25
Est.
$-0.31
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.33
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.04
The last earnings report on August 07 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 262.61K shares outstanding, the current market capitalization sits at 262.64M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLMMF38.80N/A
N/A
Holmen AB
BGLAF10.42N/A
N/A
Biogaia AB
CZBS46.00-0.05
-0.11%
Citizens Bancshares Corp.
WUXAY13.89-0.32
-2.25%
Wuxi Apptec Co Ltd.
POSAF0.05N/A
-4.15%
Posabit Systems Corporation

LFCR and Stocks

Correlation & Price change

A.I.dvisor tells us that LFCR and NBIX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and NBIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.94%
NBIX - LFCR
32%
Poorly correlated
+0.79%
SHPH - LFCR
31%
Poorly correlated
-3.26%
ALKS - LFCR
30%
Poorly correlated
+2.80%
AMRX - LFCR
29%
Poorly correlated
+1.56%
TKNO - LFCR
25%
Poorly correlated
+4.84%
More

Groups containing LFCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.94%
Pharmaceuticals: Generic
industry (224 stocks)
29%
Poorly correlated
+0.11%